Cowen and Company’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-37,700
Closed -$30K 860
2021
Q4
$30K Buy
37,700
+30,200
+403% +$443K ﹤0.01% 484
2021
Q3
$3K Hold
7,500
﹤0.01% 558
2021
Q2
$13K Sell
7,500
-7,500
-50% -$149K ﹤0.01% 528
2021
Q1
$6K Hold
15,000
﹤0.01% 508
2020
Q4
$18K Buy
+15,000
New +$225K ﹤0.01% 329
2020
Q2
Sell
-6,000
Closed -$1K 506
2020
Q1
$1K Sell
6,000
-14,000
-70% -$250K ﹤0.01% 399
2019
Q4
$21K Hold
20,000
﹤0.01% 362
2019
Q3
$147K Buy
+20,000
New +$490K 0.04% 257

Other funds holding RDUS

Cowen and Company's RDUS Position: Q1 2022 in Review

Cowen and Company sold out of Radius Health, Inc. (RDUS) in Q1 2022, closing a stake of 12,393 shares — an estimated $86K sold.

Cowen and Company first reported a position in RDUS in Q1 2020 and held it in 5 quarters. The position peaked at $93K in Q3 2021. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2022.

  • Cowen and Company reported no remaining Radius Health, Inc. position as of Q1 2022 after selling out during the quarter.
  • Cowen and Company sold 12,393 Radius Health, Inc. shares in Q1 2022, an estimated $86K.
  • Cowen and Company first reported a position in Radius Health, Inc. in Q1 2020 and held it in 5 quarters.
  • Cowen and Company's Radius Health, Inc. position peaked at $93K in Q3 2021.
  • 138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.